造影剂肾病预防的研究现状(3)
[8] Cigarroa RG,Lange RA,Williams RH,et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease[J]. Am J Med,1989,86(6 Pt 1):649-652.
[9] Solomon R,Werner C,Mann D,et al. Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents[J]. N Engl J Med,1994,331(21):1416-1420.
[10] Mueller C,Buerkl G,Buettner HJ,et al. Prevention of contrast media -associated nephropathy;randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty[J]. Arch Intern Med,2002,162(3):329-336.
, 百拇医药
[11] Huber W,Ligman K,Page M,et al. Effect of theophylline on contrast material induced nephropathy in patients with chronic renal insufficiency: controlled randomized,double-blinded study[J]. Radiology,2002,223(3):772-779.
[12] Diaz-Sandovol L,Kosowsky B,Losordo D. Acetylcysteine to prevent Angiography-related renal tissue injury(the APART trial)[J]. Am J Cardiol,2002,89(3):356-368.
[13] Baker C,Wragg A,Kurnar S,et al. A rapid protocol for the prevention of contrast-induced renal dysfunction:The RAPPID study[J]. J Am Coll Cardiol,2003,41(12):2114-2118.
, 百拇医药
[14] Konstantinos S,Elias A,Stamatis K,et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J]. Circulation,2004,110(18):2837-2842.
[15] Attallah N,Yassine L,Musial J,et al. The potential role of statins in contrast nephropathy[J]. Clin Nephrol,2004,62(4):273-278.
[16] Khanal S,Attallah N,Smith DE,et al. Statin therapy reduces contrast-induced nephropathy:An analysis of contemporary percutaneous interventions[J]. Am J Med,2005,118(8):843-849.
, 百拇医药
[17] Sketch MH,Whelton A,Schollmayer E,et al. Prevention of contrast media-induced renal dysfunction with prostagland in El:a randomized,double-blind,placebo-controlled study[J]. Am J Therap,2001,8(3):155-162.
[18] Merten GJ,Burgess WP,Gray LV,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate:a randomized controlled trial[J]. JAMA,2004,291(19):2328-2334.
[19] Vincent L. Radiocontrast media-induced nephrotoxicity in patients with renal failure:rationate for a new double-blind,prospective,randomizd trial testing calcium channel antagonists[J]. Nephrol Dial Transpl,2002, 17(8):1362-1364.
, 百拇医药
[20] Carraro M,Mancini W ,Artern M,et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration[J]. Nephrol Dial Transplant,1996,11(3):444-448.
[21] Kini AA,Sharma SK. Managing the high-risk patient:experience with Fenoldopam,a selective dopamine receptor agonist,in prevention of ra diocontrast nephropathy during percutaneora coronary intervention[J]. Rev Cardiovasc Med,2001,2(Suppl 1):19-25.
, http://www.100md.com
[22] Stone G,McCullough P,Tumlin J,et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy:a randomized controlled trial[J]. JAMA,2003,290(17):2284-2291.
[23] Solomon R,Werner C,Mann D,et al. Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents[J]. N Engl Jmed,1994,331(21):1416-1420.
[24] Wang A,Holcslaw T,Bashore M,et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antoganism[J]. Kidney Int,2000, 57(4):1675-1680.
[25] Marenzi G,Lauri G,Campodonico J,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high- risk patients[J]. Am J Med,2006,119(2):155-162.
(收稿日期:2009-08-25), http://www.100md.com(方 中 综述 喻 卓 审校)
[9] Solomon R,Werner C,Mann D,et al. Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents[J]. N Engl J Med,1994,331(21):1416-1420.
[10] Mueller C,Buerkl G,Buettner HJ,et al. Prevention of contrast media -associated nephropathy;randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty[J]. Arch Intern Med,2002,162(3):329-336.
, 百拇医药
[11] Huber W,Ligman K,Page M,et al. Effect of theophylline on contrast material induced nephropathy in patients with chronic renal insufficiency: controlled randomized,double-blinded study[J]. Radiology,2002,223(3):772-779.
[12] Diaz-Sandovol L,Kosowsky B,Losordo D. Acetylcysteine to prevent Angiography-related renal tissue injury(the APART trial)[J]. Am J Cardiol,2002,89(3):356-368.
[13] Baker C,Wragg A,Kurnar S,et al. A rapid protocol for the prevention of contrast-induced renal dysfunction:The RAPPID study[J]. J Am Coll Cardiol,2003,41(12):2114-2118.
, 百拇医药
[14] Konstantinos S,Elias A,Stamatis K,et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J]. Circulation,2004,110(18):2837-2842.
[15] Attallah N,Yassine L,Musial J,et al. The potential role of statins in contrast nephropathy[J]. Clin Nephrol,2004,62(4):273-278.
[16] Khanal S,Attallah N,Smith DE,et al. Statin therapy reduces contrast-induced nephropathy:An analysis of contemporary percutaneous interventions[J]. Am J Med,2005,118(8):843-849.
, 百拇医药
[17] Sketch MH,Whelton A,Schollmayer E,et al. Prevention of contrast media-induced renal dysfunction with prostagland in El:a randomized,double-blind,placebo-controlled study[J]. Am J Therap,2001,8(3):155-162.
[18] Merten GJ,Burgess WP,Gray LV,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate:a randomized controlled trial[J]. JAMA,2004,291(19):2328-2334.
[19] Vincent L. Radiocontrast media-induced nephrotoxicity in patients with renal failure:rationate for a new double-blind,prospective,randomizd trial testing calcium channel antagonists[J]. Nephrol Dial Transpl,2002, 17(8):1362-1364.
, 百拇医药
[20] Carraro M,Mancini W ,Artern M,et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration[J]. Nephrol Dial Transplant,1996,11(3):444-448.
[21] Kini AA,Sharma SK. Managing the high-risk patient:experience with Fenoldopam,a selective dopamine receptor agonist,in prevention of ra diocontrast nephropathy during percutaneora coronary intervention[J]. Rev Cardiovasc Med,2001,2(Suppl 1):19-25.
, http://www.100md.com
[22] Stone G,McCullough P,Tumlin J,et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy:a randomized controlled trial[J]. JAMA,2003,290(17):2284-2291.
[23] Solomon R,Werner C,Mann D,et al. Effects of saline,mannitol,and furosemide on acute decreases in renal function induced by radiocontrast agents[J]. N Engl Jmed,1994,331(21):1416-1420.
[24] Wang A,Holcslaw T,Bashore M,et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antoganism[J]. Kidney Int,2000, 57(4):1675-1680.
[25] Marenzi G,Lauri G,Campodonico J,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high- risk patients[J]. Am J Med,2006,119(2):155-162.
(收稿日期:2009-08-25), http://www.100md.com(方 中 综述 喻 卓 审校)